Pharma Resources (Shanghai) Co Ltd Class A 301230
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 36.77
- Day Range
- CNY 35.17–36.30
- 52-Week Range
- CNY 21.16–57.50
- Bid/Ask
- CNY 35.95 / CNY 35.96
- Market Cap
- CNY 3.87 Bil
- Volume/Avg
- 7.0 Mil / 6.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 255.07
- Price/Sales
- 7.98
- Dividend Yield (Trailing)
- 1.36%
- Dividend Yield (Forward)
- 1.36%
- Total Yield
- 1.39%
Company Profile
Pharma Resources (Shanghai) Co Ltd is engaged in the drug discovery, research and development of pharmaceutical processes, and commercial production of API intermediates.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,047
- Website
- http://www.pharmaresources.cn
Comparables
Valuation
|
Metric
|
301230
|
688278
|
301089
|
|---|---|---|---|
Price/Earnings (Normalized) | 255.07 | 37.58 | 20.09 |
Price/Book Value | 3.51 | 11.70 | 3.06 |
Price/Sales | 7.98 | 10.52 | 11.89 |
Price/Cash Flow | 240.21 | 41.15 | — |
Price/Earnings
301230
688278
301089
Financial Strength
|
Metric
|
301230
|
688278
|
301089
|
|---|---|---|---|
Quick Ratio | 3.44 | 3.12 | 3.18 |
Current Ratio | 3.96 | 3.84 | 4.56 |
Interest Coverage | 2.98 | 1,367.33 | −1,600.44 |
Quick Ratio
301230
688278
301089
Profitability
|
Metric
|
301230
|
688278
|
301089
|
|---|---|---|---|
Return on Assets (Normalized) | 1.10% | 29.32% | −3.77% |
Return on Equity (Normalized) | 1.40% | 36.30% | −4.33% |
Return on Invested Capital (Normalized) | 1.15% | 35.79% | −4.49% |
Return on Assets
301230
688278
301089
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Kyhyggjw | Gkvks | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Rxhslxjz | Phbxbr | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Slzgbpnv | Wtjxbc | $108.2 Bil | |
MRNA
| Moderna Inc | Zkkpmzth | Qrj | $50.9 Bil | |
ARGX
| argenx SE ADR | Bxgpnrqn | Tnkt | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Rgygdghyh | Ctlcb | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Wmwnzjblf | Kzwhlj | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Ympfcqvl | Khqltgc | $14.6 Bil | |
INCY
| Incyte Corp | Pxdtsqxt | Sjydrx | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Bmpmszhcs | Ypncrz | $12.3 Bil |